NEW MJ NEWS

Verano to Report Third Quarter 2023 Financial Results on November 8, 2023

Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced that it plans to release financial results for the third quarter ending September 30, 2023, before the market opens on Wednesday, November 8, 2023.

A conference call and webcast with analysts and investors is scheduled for November 8, 2023 at 8:30 a.m. ET / 7:30 a.m. CT to discuss the results and answer investor and participant questions.

Investors and participants can register in advance for the call by visiting: https://conferencingportals.com/event/sxTSCKLn

After registering, instructions will be shared on how to join the call for those who wish to dial in.

On November 8, 2023, the live webcast can be accessed via the following link: https://events.q4inc.com/attendee/254800729

The live and archived webcast will be available on the Events and Presentations page of the Company’s investor relations website at investors.verano.com.

About Verano
Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF), one of the U.S. cannabis industry’s leading companies based on historical revenue, geographic scope and brand performance, is a vertically integrated, multi-state operator embracing a mission of saying Yes to plant progress and the bold exploration of cannabis. Verano offers a superior cannabis shopping experience in medical and adult use markets under the Zen Leaf™ and MÜV™ dispensary banners and produces a comprehensive suite of high-quality, regulated cannabis products sold under its diverse portfolio of trusted consumer brands including Verano™, MÜV™, Savvy™, BITS™, Encore™, and Avexia™. Verano’s active operations span 13 U.S. states, comprised of 14 production facilities with over 1,000,000 square feet of cultivation capacity. Learn more at www.verano.com.

Contacts:
Investors
Verano
Julianna Paterra, CFA
VP, Investor Relations
julianna.paterra@verano.com

Media
Verano
Steve Mazeika
VP, Communications
steve.mazeika@verano.com
312-348-4430


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Aphria Inc. (APHA) to announce fourth quarter and fiscal 2019 financial results on August 1, 2019

Aphria Inc. to announce fourth quarter and fiscal 2019 financial results on…

Canopy USA, LLC (CGC) Announces Appointment of Mr. M. Brooks Jorgensen as President

Canopy USA Announces Appointment of Mr. M. Brooks Jorgensen as President Canopy…

Cannabis Science, Inc. (CBIS) Releases Clinical Drug-Development Pipeline

Cannabis Science Releases Clinical Drug-Development Pipeline as it Transitions Into Clinical Trials;…

$MJNA Announces Clinical Trial Launch of MedChew RX

MJNA’s Investment Company AXIM Biotech Announces Clinical Trial Launch of MedChew RX…